X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
female (44) 44
index medicus (35) 35
oncology (32) 32
middle aged (27) 27
aged (23) 23
breast cancer (23) 23
surgery (20) 20
breast neoplasms - pathology (17) 17
adult (16) 16
breast neoplasms - surgery (14) 14
article (13) 13
biopsy (12) 12
medicine & public health (12) 12
neoplasm staging (12) 12
breast neoplasms - drug therapy (10) 10
cancer (10) 10
prognosis (10) 10
treatment outcome (10) 10
mammography (9) 9
united states (9) 9
women (9) 9
aged, 80 and over (8) 8
breast neoplasms - mortality (8) 8
breast neoplasms - therapy (8) 8
immunohistochemistry (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
breast neoplasms - diagnosis (7) 7
risk factors (7) 7
breast neoplasms - diagnostic imaging (6) 6
breast neoplasms - metabolism (6) 6
breast neoplasms - prevention & control (6) 6
chemoprevention (6) 6
chemotherapy (6) 6
disease-free survival (6) 6
risk assessment (6) 6
surgical oncology (6) 6
antineoplastic agents - therapeutic use (5) 5
breast carcinoma (5) 5
chemotherapy, adjuvant (5) 5
diagnosis (5) 5
exercise (5) 5
mastectomy (5) 5
nccn clinical practice guidelines (5) 5
neoadjuvant therapy (5) 5
nutrition (5) 5
physical-activity (5) 5
preoperative chemotherapy (5) 5
receptor, erbb-2 - metabolism (5) 5
survival (5) 5
therapy (5) 5
weight loss (5) 5
breast neoplasms - genetics (4) 4
carcinoma (4) 4
care and treatment (4) 4
combined modality therapy (4) 4
comorbidity (4) 4
diet (4) 4
health aspects (4) 4
human chorionic gonadotropin (4) 4
hyperplasia (4) 4
lumpectomy (4) 4
lymphatic metastasis (4) 4
magnetic resonance imaging (4) 4
male (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm recurrence, local (4) 4
obesity (4) 4
obesity - therapy (4) 4
obstetrics & gynecology (4) 4
osteosarcoma (4) 4
phyllodes tumor (4) 4
recurrence (4) 4
risk (4) 4
screening (4) 4
surgeons (4) 4
surgical adjuvant breast (4) 4
survivors (4) 4
tamoxifen (4) 4
age factors (3) 3
biomarkers, tumor (3) 3
breast neoplasms - complications (3) 3
breast oncology (3) 3
cancer survivors (3) 3
carcinoma in situ (3) 3
carcinoma, squamous cell - pathology (3) 3
cells (3) 3
clinical trials as topic (3) 3
disease (3) 3
expression (3) 3
hematology, oncology and palliative medicine (3) 3
mastectomy, segmental (3) 3
medicine, general & internal (3) 3
mortality (3) 3
multivariate analysis (3) 3
original reports (3) 3
otorhinolaryngology (3) 3
outcomes (3) 3
overweight (3) 3
overweight - therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4055 - 4065
Purpose: Cyclin-dependent kinase (CDK) 4/6 drives cell proliferation in estrogen receptor-positive (ER+) breast cancer. This single-arm phase II neoadjuvant... 
TRIAL | AROMATASE INHIBITOR | 1ST-LINE TREATMENT | RETINOBLASTOMA PROTEIN | ONCOLOGY | INTRINSIC SUBTYPE | IN-VIVO | DOUBLE-BLIND | LETROZOLE | CELL-PROLIFERATION | POSTMENOPAUSAL WOMEN | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Breast Neoplasms - surgery | Triazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Class I Phosphatidylinositol 3-Kinases - genetics | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Nitriles - administration & dosage | Pyridines - adverse effects | Adult | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - administration & dosage | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Aged | Cell Proliferation - drug effects | Mutation | Neoplasm Staging | Cell proliferation | Anastrozole | Estrogens | Cyclin-dependent kinases | Estrogen | Estrogen receptors | Breast cancer | Kinases | Gene expression | Patients | ErbB-2 protein | Cyclin-dependent kinase 4 | Cyclin-dependent kinase | E2F protein | Inhibitors | Experimental design | Surgery | Cell cycle | Breast | Cancer | breast cancer | neoadjuvant | anastrozole | CDK4 | palbociclib
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 1049 - 1062
Journal Article
Surgical Clinics of North America, ISSN 0039-6109, 08/2018, Volume 98, Issue 4, pp. 677 - 685
As more genetic information becomes available to inform breast cancer treatment, screening, and risk-reduction approaches, clinicians must become more... 
Multigene panel testing | BRCA | Genetic counseling | Risk-reducing mastectomy | Contralateral prophylactic mastectomy | SURGERY | PATIENT-REPORTED SATISFACTION | MUTATION-NEGATIVE WOMEN | POSITIVE FAMILIES | BODY-IMAGE | FAMILY-HISTORY | CARRIERS | BILATERAL MASTECTOMY | HIGH-RISK | NIPPLE-SPARING MASTECTOMY | BRCA2 MUTATION
Journal Article
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2018, Volume 268, Issue 3, pp. 442 - 448
OBJECTIVE:The aim of this study is to examine the relationship between the sex pay gap in a large academic department of surgery and a recently instituted... 
GENDER | WORK | sex pay gap | sex equity | compensation plan | surgery | Surgeons | Practice | Compensation and benefits
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 12/2016, Volume 17, Issue 6, pp. 676 - 695
This review focuses on our efforts to translate a low-toxicity retinoid X receptor-selective agonist, UAB30, to the clinic for the prevention of breast... 
Breast cancer | Tissue selective rexinoids | RXR | Chemoprevention | Rexinoids | UAB30 | NEGATIVE MAMMARY-TUMORS | CHEMISTRY, MEDICINAL | CRYSTAL-STRUCTURE | 9-CIS-RETINOIC ACID | NUCLEAR RECEPTOR | GENE-EXPRESSION | POLYUNSATURATED FATTY-ACIDS | RETINOID-X-RECEPTOR | LIGAND-BINDING DOMAIN | TRANSGENIC MOUSE MODELS | AROMATASE INHIBITORS
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2008, Volume 26, Issue 6, pp. 897 - 906
Purpose To administer the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib to patients with operable untreated breast cancer during... 
TRIAL | LUNG-CANCER | IN-VITRO | GEFITINIB | GROWTH-FACTOR-RECEPTOR | ONCOLOGY | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | PHASE-II | COMBINATION | POSTMENOPAUSAL PATIENTS | Erlotinib Hydrochloride | Immunohistochemistry | Neoplasms, Hormone-Dependent - metabolism | Breast Neoplasms - surgery | Receptors, Estrogen - metabolism | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Ki-67 Antigen - metabolism | Antineoplastic Agents - therapeutic use | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Tandem Mass Spectrometry | Receptor, Epidermal Growth Factor - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Antineoplastic Agents - pharmacology | Chemotherapy, Adjuvant | In Situ Nick-End Labeling | Neoplasms, Hormone-Dependent - surgery | Treatment Outcome | Breast Neoplasms - drug therapy | Protein Kinase Inhibitors - blood | Quinazolines - blood | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms, Hormone-Dependent - pathology | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Neoadjuvant Therapy - methods | Antineoplastic Agents - blood | Aged | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms, Hormone-Dependent - drug therapy | Neoplasm Staging | Quinazolines - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 4/2008, Volume 15, Issue 4, pp. 1032 - 1039
Journal Article
Journal of Surgical Research, ISSN 0022-4804, 01/2019, Volume 233, pp. 32 - 35
Right-sizing instrument trays reduce processing and replacement costs, physical strain, and turnover times. Historically, a 98-instrument head and neck tray... 
Lumpectomy | Efficiency | Cost savings | Operating room | Surgical tray optimization | Breast surgery | SURGERY | SURGICAL-INSTRUMENTS | STANDARDIZATION | QUALITY | REDUCTION | Physical instruments | Medical informatics
Journal Article
Journal Article